335 related articles for article (PubMed ID: 27665585)
1. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
[TBL] [Abstract][Full Text] [Related]
2. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
3. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
4. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
5. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
Soran A; Menekse E; Girgis M; DeGore L; Johnson R
Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
[TBL] [Abstract][Full Text] [Related]
7. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population.
Li X; Huang H; Lin Q; Yu Q; Zhou Y; Long W; Wang N
J Surg Res; 2017 Apr; 210():132-138. PubMed ID: 28457319
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
Bevilacqua JL; Kattan MW; Changhong Y; Koifman S; Mattos IE; Koifman RJ; Bergmann A
Ann Surg Oncol; 2012 Aug; 19(8):2580-9. PubMed ID: 22395997
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
10. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer related lymphedema in patients with different loco-regional treatments.
Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
16. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
17. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the Prevention of Breast Cancer-Related Clinical Lymphedema After Axillary Lymph Node Dissection.
Ozmen T; Lazaro M; Zhou Y; Vinyard A; Avisar E
Ann Surg; 2019 Dec; 270(6):1156-1160. PubMed ID: 29794843
[TBL] [Abstract][Full Text] [Related]
19. Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
McDuff SGR; Mina AI; Brunelle CL; Salama L; Warren LEG; Abouegylah M; Swaroop M; Skolny MN; Asdourian M; Gillespie T; Daniell K; Sayegh HE; Naoum GE; Zheng H; Taghian AG
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):62-70. PubMed ID: 30165125
[TBL] [Abstract][Full Text] [Related]
20. Quality of life of breast cancer patients with lymphedema.
Velanovich V; Szymanski W
Am J Surg; 1999 Mar; 177(3):184-7; discussion 188. PubMed ID: 10219851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]